… This study sought to determine the impact of weight and body mass index (BMI) on the
safety and efficacy of direct-acting oral anticoagulants (DOACs) compared with warfarin in …

… oral anticoagulant (DOAC)‐treated patients about safety and efficacy in extremes of body
weight… The aims of this systematic review were to investigate the association of body weight …

… (VTE), anticoagulation is mandatory to prevent thrombus … -weight heparin (LMWH) followed
by oral anticoagulation with … efficacy of DOACs compared to VKA in obese, normal-weight…

… use of direct oral anticoagulants (DOACs) in patients with extremes of body weight remains
… to warfarin on safety and efficacy outcomes in extreme body weight patients. This multi-center…

… One might assume that the majority of the primary outcome events occurred in those at the
higher extreme of body weight, however this was not found to be the case in the present study…

… anticoagulation in patients with AF and elevated body weight has become even more
essential to address in routine clinical practice. The purpose of this study was to evaluate efficacy …

… From a total of 135,939 new users of oral anticoagulants (OACs) since January 2014, 7,576
warfarin users and 14,103 direct oral anticoagulant (DOAC) users were included in this study…

… higher doses to be required with increasing body weight. Monitoring of INR to achieve a
therapeutic range ensures effective and safe oral anticoagulation even in those with Class II and …

… the safety and efficacy of direct oral anticoagulants (DOACs) in patients of extreme weights
are … the safety and efficacy of DOAC therapy in patients of extreme weights for the treatment of …

… antagonist oral anticoagulants (NOACs) exert their anticoagulant … weight (and its correlates,
ie, surface area and body mass index, BMI), extremes in body weight may affect their efficacy …